| Date | Form | Description | Docs | XBRL | Pages |
| 05/20/16 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
34 |
| 02/19/16 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
30 |
| 08/18/15 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
37 |
| 05/22/15 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
44 |
| 03/09/15 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
39 |
| 09/15/14 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
66 |
| 06/16/14 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
63 |
| 03/17/14 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
|
74 |
| 09/20/13 | 10-Q/A | Quarterly report pursuant to sections 13 or 15(d) |
|
|
3 |
| 09/16/13 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
66 |
Latest News & Events
Anixa Biosciences Names Cancer Vaccine Pioneer Dr. Ian H. Frazer to Scientific Advisory Board
Read More...Anixa Biosciences Announces University of Maryland School of Medicine to Join Cchek™ Prostate Cancer Study
Read More...Anixa Biosciences Commences Collaboration with Potomac Urology Center on Cchek™ Prostate Cancer Study
Read More...Cancer of the Lung, Breast, Colon, Prostate, and Stomach are the five most prevalent cancers worldwide.